{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-262541","form_type":"8-K","ticker":"KPTI","cik":"0001503802","company_name":"Karyopharm Therapeutics Inc.","filed_at":"2024-11-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.617011+00:00","generated_at":"2026-05-29T21:45:56.073131+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Karyopharm appoints Kristin Abate as VP, Chief Accounting Officer, effective Nov 20, 2024","bullets":["Kristin Abate appointed Vice President, Chief Accounting Officer, and Assistant Treasurer, effective November 20, 2024.","She continues as interim principal financial officer; designated as principal accounting officer.","Abate has been with Karyopharm since July 2019, most recently as VP Accounting, Corporate Controller, Assistant Treasurer.","Prior to Karyopharm, she spent 12 years at PricewaterhouseCoopers LLP; CPA with MS in Accountancy from Boston College."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-262541","json":"https://secwatch.observer/filing/0001193125-24-262541.json","markdown":"https://secwatch.observer/filing/0001193125-24-262541.md","text":"https://secwatch.observer/filing/0001193125-24-262541.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1503802/000119312524262541/0001193125-24-262541-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1503802/000119312524262541/d858096d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T21:45:56.073131+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"96f8beb90e","claim":"Kristin Abate was appointed as Vice President, Chief Accounting Officer at Karyopharm Therapeutics Inc..","evidence_excerpt":"On November 20, 2024, Karyopharm Therapeutics Inc. (the “Company”) announced the appointment of Kristin Abate, the Company’s Vice President, Accounting, Corporate Controller and Assistant Treasurer, as the Company’s Vice President, Chief Accounting Officer, and Assistant Treasurer, effective November 20, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1503802/000119312524262541/0001193125-24-262541-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Vice President, Chief Accounting Officer"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}